US Stem Cell Inc (USRM)

[GoldenMind]

Found this, and thought it was interesting

http://www.businesswire.com/news/home/20170630005691/en/Global-Autologous-Cell-Therapy-Market-Grow-CAGR

"There has been an increased demand for providing effective drugs for cardiac and degenerative disorders globally. Prior to the advent of autologous cell therapies, there was no effective drug to repair a damaged heart. The discovery of possible cardiac autologous cells opened new possibilities for repairing damaged cardiac tissue caused by acute myocardial infarction or coronary artery disease.

There are approximately 19 product candidates being developed for the treatment of cardiac disorders, with eight in Phase III and six in Phase II development stages. Some of the companies that are developing these drugs include Shire, Athersys, Japan Regenerative Medicine, MyoCell, and Celyad. These products are expected to be launched during the forecast period and will have a substantial impact on the market growth."

I'm here for good. Thanks all :) revs will be coming in around 10 mil a year for 2018 at this rate of growth. Its only a matter of time before more private equity money comes pouring in to open more clinics and to fund their trials.